Hsbc Holdings PLC Takes Position in Oscar Health, Inc. $OSCR

Hsbc Holdings PLC bought a new position in Oscar Health, Inc. (NYSE:OSCR) during the fourth quarter, Holdings Channel reports. The fund bought 33,969 shares of the company’s stock, valued at approximately $486,000.

Several other institutional investors also recently modified their holdings of OSCR. Quarry LP lifted its position in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the period. Jones Financial Companies Lllp grew its holdings in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio purchased a new stake in Oscar Health in the first quarter worth about $30,000. Fifth Third Bancorp increased its stake in shares of Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares in the last quarter. Finally, Binnacle Investments Inc bought a new position in shares of Oscar Health during the second quarter valued at approximately $75,000. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on OSCR shares. Wolfe Research started coverage on shares of Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating for the company. Robert W. Baird upped their price target on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. UBS Group raised their price objective on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Finally, Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $20.78.

Oscar Health Stock Down 5.7%

NYSE:OSCR opened at $28.86 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market cap of $8.70 billion, a P/E ratio of -48.91, a P/E/G ratio of 1.71 and a beta of 2.34. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.10. The firm has a 50-day simple moving average of $26.77 and a two-hundred day simple moving average of $18.88.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same quarter in the prior year, the firm posted $0.92 earnings per share. The business’s revenue was up 52.6% on a year-over-year basis. Analysts predict that Oscar Health, Inc. will post 0.59 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In other Oscar Health news, insider Adam Mcananey sold 9,859 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $216,306.46. Following the sale, the insider directly owned 218,096 shares in the company, valued at approximately $4,785,026.24. This trade represents a 4.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 12,475 shares of the stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $273,701.50. Following the sale, the insider owned 259,057 shares in the company, valued at approximately $5,683,710.58. This represents a 4.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 3,662,466 shares of company stock valued at $105,145,815 over the last ninety days. Corporate insiders own 22.64% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.